Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roy First

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation|July 9, 2005
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionChristin C Rogers, Rita R Alloway, Joseph F Buell, et al.
Transplantation|September 28, 2004
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters, Kristin N Spinola, John C West, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Transplantation|February 25, 2005
The influence of immunomodulatory diets on transplant success and complicationsJ Wesley Alexander, Timothy J Metze, Matthew J McIntosh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionRobyn E Boardman, Rita R Alloway, J Wesley Alexander, et al.
Gastroenterology|March 16, 2021
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled StudyCiarán P Kelly, Joseph A Murray, Daniel A Leffler, et al.
Clinical Transplants|July 22, 2008
Corticosteroid elimination: the Cincinnati experienceE Steve Woodle, Rita Alloway, Adele Rike, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
The Israel Penn International Transplant Tumor RegistryBeth Ann Witherow, Gregory S Roth, Mark A Carrozza, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation|July 9, 2005
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionChristin C Rogers, Rita R Alloway, Joseph F Buell, et al.
Transplantation|September 28, 2004
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters, Kristin N Spinola, John C West, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Transplantation|February 25, 2005
The influence of immunomodulatory diets on transplant success and complicationsJ Wesley Alexander, Timothy J Metze, Matthew J McIntosh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionRobyn E Boardman, Rita R Alloway, J Wesley Alexander, et al.
Gastroenterology|March 16, 2021
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled StudyCiarán P Kelly, Joseph A Murray, Daniel A Leffler, et al.
Clinical Transplants|July 22, 2008
Corticosteroid elimination: the Cincinnati experienceE Steve Woodle, Rita Alloway, Adele Rike, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
The Israel Penn International Transplant Tumor RegistryBeth Ann Witherow, Gregory S Roth, Mark A Carrozza, et al.
Pageof 6